Trial intelligence / Profile preview

Ziprasidone vs Olanzapine, Risperidone or Quetiapine in Schizophrenia

NCT00159770Phase 3Completed

Sponsor
Viatris
Start
Nov 2001
Modality
Small Molecules
Countries
4
01

Overview

A Phase 3 trial of ziprasidone in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by Viatris. Started Nov 2001; status: completed.

02

Drugs

ziprasidone
03

Conditions

schizophreniaschizoaffective disorderschizophreniform disorder

Beyond the preview

Go deeper on NCT00159770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00159770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call